- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03948217
The Effects of Artificial Lighting on Affective and Core Symptoms of Eating Disorder (METROPOLIS)
The Effects of Artificial Lighting on Affective and Core Symptoms of Eating Disorder - a Pilot Study
The primary objective of this pilot study is to explore the effect of artificial lighting on affective symptoms, and the secondary aim is to explore the effect of artificial lighting on core symptoms of eating disorders (ED).
Several lines of evidence, albeit from hypothesis generation studies, suggest that artificial lighting may have a positive effect on well-being, mental health and affective symptoms in ED. The rationale of this study is to investigate the effects of artificial lighting on affective symptoms and cores symptoms of ED in inpatients undergoing weight restoration/treatment for ED.
Study design: Single-blind, controlled, pilot intervention study with circadian light (CL) comparing two CL regimens effects on mood symptoms.
Planned number of subjects: 16 patients with a ICD-10 diagnosis of Anorexia Nervosa, that completes exposure to at least three weeks of the two different CL regimens (L1 and L2) in any order.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The primary objective of this pilot study is to explore the effect of artificial lighting on affective symptoms, and the secondary aim is to explore the effect of artificial lighting on core symptoms of eating disorders (ED).
If an effect is indicated, the study will provide information on how to improve light exposure to ED patients in psychiatric treatment units. In addition, the outcomes may help identify a better system for measurement and adjustment of the specific light variables of colour temperature and light intensity.
Several lines of evidence, albeit from hypothesis generation studies, suggest that artificial lighting may have a positive effect on well-being, mental health and affective symptoms in ED. This is the rationale to investigate the effects of artificial lighting on affective symptoms and cores symptoms of ED in inpatients undergoing weight restoration/treatment for ED.
Study design: Single-blind, controlled, pilot intervention study with circadian light (CL) comparing two CL regimens effects on mood symptoms.
Planned number of subjects: 16 patients with a International Classification of Disorders 10 (ICD-10) diagnosis of Anorexia Nervosa, that completes exposure to at least three weeks of the two different CL regimens (L1 and L2) in any order.
Location: Mental Health Center Ballerup, department 14 (currently Department 5).
Diagnostic inventory: Eating Disorder Examination-Questionnaire (EDE-Q)
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Capitol Region
-
Ballerup, Capitol Region, Denmark, 2750
- Mental Health Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Primary diagnosis of Anorexia Nervosa (AN) or Bulimia Nervosa (BN) or Eating Disorder Not Otherwise specified (EDNOS)
- Age ≥18 and <65
Exclusion Criteria:
- Forced care
- Non-primary psychiatric disorder other than AN, BN, or EDNOS
- Binge Eating disorder
- Somatic unstable condition
- High suicidal behavior or risk
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: L1
regimen L1 has overall higher intensity, higher color temperature and less light fluctuations
|
Circadian lighting regimen with one major fluctuation, high light intensity and color
|
Active Comparator: L2
regimen L2 has lower intensity, lower color temperature and more light fluctuations.
|
Circadian lighting regimen with one major fluctuation, high light intensity and color
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
3 week change in total score of Major Depression Inventory
Time Frame: 3 weeks change from baseline
|
depression scoring, change in total score over three weeks.
range 0-50.
Higher values means more depressed.
Mild depression: MDI total score from 21 to 25. Moderate depression: MDI total score from 26 to 30.
Severe depression: MDI total score of 31 or higher.
|
3 weeks change from baseline
|
3 week change in total score of Eating Disorder Inventory 2
Time Frame: 3 weeks change from baseline
|
Eating disorder symptoms total score change over 3 weeks.
range 0-273.
Higher score means more Eating disorder symptoms.
|
3 weeks change from baseline
|
3 week change in video images based measure of Physical activity
Time Frame: 3 weeks change in physical activity from baseline
|
video images based measure of quantity of physical activity
|
3 weeks change in physical activity from baseline
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
3 week change in BMI
Time Frame: 3 week change as a measure of weight change
|
change in Body Mass index
|
3 week change as a measure of weight change
|
3 week change in Visual analogue scale of mood
Time Frame: 3 weeks change from baseline
|
self assessed measure of mood symptoms, range 1-10.
Higher score means more symptoms and feeling worse.
|
3 weeks change from baseline
|
3 week change in melatonin levels
Time Frame: 3 weeks change from baseline
|
urinary levels of melatonin
|
3 weeks change from baseline
|
3 week change in serotonin levels
Time Frame: 3 weeks change from baseline
|
Blood levels of serotonin
|
3 weeks change from baseline
|
3 week change in cortisol levels
Time Frame: 3 weeks change from baseline
|
Urinary levels of cortisol as a measure of stress
|
3 weeks change from baseline
|
Collaborators and Investigators
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- H-17022914
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Anorexia Nervosa
-
Rosemary Claire RodenChildren's Miracle NetworkEnrolling by invitationBulimia Nervosa | Impulsive Behavior | Purging (Eating Disorders) | Eating Disorders | Eating Disorders in Adolescence | Anorexia Nervosa/Bulimia | Anorexia in Adolescence | Anorexia Nervosa, Atypical | Anorexia Nervosa, Binge Eating/Purging TypeUnited States
-
Fundació Institut de Recerca de l'Hospital de la...Fundació La Marató de TV3RecruitingAnorexia Nervosa | Anorexia Nervosa in Remission | Anorexia Nervosa Restricting TypeSpain
-
Duke UniversityCompletedAdolescent Anorexia Nervosa | Subthreshold Anorexia NervosaUnited States
-
University of California, San DiegoRecruitingAnorexia Nervosa | Bulimia Nervosa | Atypical Anorexia Nervosa | Atypical Bulimia NervosaUnited States
-
Stanford UniversityNational Institute of Mental Health (NIMH); National Institutes of Health (NIH) and other collaboratorsCompletedAnorexia Nervosa | Anorexia | Eating Disorder | Eating Disorders in Adolescence | Anorexia in Adolescence | Anorexia Nervosa, Atypical | Anorexia Nervosa Restricting Type | Anorexia in ChildrenUnited States
-
Linnaeus UniversityGöteborg University; Linkoeping UniversityRecruitingBulimia Nervosa | Major Depression | Anorexia Nervosa/BulimiaSweden
-
Umeå UniversityActive, not recruitingAnorexia Nervosa | Anorexia in Adolescence | Anorexia Nervosa, AtypicalSweden
-
Yeshiva UniversityYale UniversityRecruitingAnorexia Nervosa | Bulimia Nervosa | Anorexia Nervosa, Atypical | Bulimia; AtypicalUnited States
-
The Miriam HospitalUnknownEating Disorders in Adolescence | Anorexia Nervosa/Bulimia | Anorexia Nervosa Restricting TypeUnited States
-
University of California, San DiegoRecruitingAnorexia Nervosa | Atypical Anorexia NervosaUnited States
Clinical Trials on Circadian Lighting regimen
-
Icahn School of Medicine at Mount SinaiRecruiting
-
Ove AndersenAalborg University; Albertslund Kommune; Gate 21; Chromaviso A/SCompletedElderly Housing Residents With Frailty or DementiaDenmark
-
University of AarhusAarhus University HospitalCompleted
-
Advocate Health CareCompletedColorectal Cancer Screening | Colon Adenomatous PolypUnited States
-
Icahn School of Medicine at Mount SinaiRecruitingSleep Disturbance | Alzheimer's DiseaseUnited States
-
Icahn School of Medicine at Mount SinaiCompletedAlzheimer's DiseaseUnited States
-
Arizona State UniversityWithdrawnSleep | Alertness | Daytime Cognitive Performance
-
Well Living Lab, Inc.Mayo ClinicRecruitingPhysical Activity | Sleep | Cognitive Function | Social IsolationUnited States
-
Icahn School of Medicine at Mount SinaiRecruitingAlzheimer Disease | Mild Cognitive ImpairmentUnited States
-
Icahn School of Medicine at Mount SinaiActive, not recruiting